Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00055991 · ClinicalTrials.gov registry record · Phase 1
Bexarotene in Preventing Breast Cancer in Women at Genetic Risk
A Phase 1 study, sponsored by Baylor Breast Care Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 87
- Enrollment target
NCT00055991 is a Phase 1 study that has completed, run by Baylor Breast Care Center. The registered enrollment target is 87 participants.
The verdict
NCT00055991, a Phase 1 study, has completed, sponsored by Baylor Breast Care Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 87 participants
- Enrollment target
Study Summary
RATIONALE: Chemoprevention therapy uses certain drugs to try to prevent the development or recurrence of cancer. It is not yet known whether bexarotene is effective in preventing breast cancer. PURPOSE: Randomized clinical trial to study the effectiveness of bexarotene in preventing breast cancer in women who are at genetic risk of developing breast cancer.
Interventions
- DRUG bexarotene
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2001-09 |
| Est. Completion | 2006-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00055991
The ClinicalTrials.gov registry entry for NCT00055991 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 87 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor Breast Care Center, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which bexarotene is the first listed.
NCT00055991 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00055991 about?
NCT00055991 is a clinical study titled "Bexarotene in Preventing Breast Cancer in Women at Genetic Risk". RATIONALE: Chemoprevention therapy uses certain drugs to try to prevent the development or recurrence of cancer. It is not yet known whether bexarotene is effective in preventing breast cancer. PURPOSE: Randomized clinical trial to study the effectiveness of bexarotene in preventing breast cancer i...
What is the current status of trial NCT00055991?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 87 participants. The study started on 2001-09. Estimated completion is 2006-09.
What interventions are being tested in trial NCT00055991?
The interventions under investigation include: bexarotene (DRUG).
Who is sponsoring clinical trial NCT00055991?
This trial is sponsored by Baylor Breast Care Center, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.